Alternative embryo transfer on day 3 or day 5 for reducing the risk of multiple gestations
- PMID: 11464577
- PMCID: PMC3455334
- DOI: 10.1023/a:1016651016502
Alternative embryo transfer on day 3 or day 5 for reducing the risk of multiple gestations
Abstract
Purpose: This study was carried out to reduce the possibility of high-order multiple gestations and the failure of embryo transfer by determining their replacement date based on the number and quality of 2-day embryos.
Methods: All zygotes were cocultured with cumulus cells in 10 microliters of YS medium containing 10% human follicular fluid (hFF) for 48 or 96 hr. In period I, all embryos were transferred on day 3 (1032 cycles). In period II, the embryos were transferred on either day 3 or day 5 by determining their replacement date based on the number and quality of 2-day embryos: there were 2701 patients in whom embryos were replaced on day 3 (in the case that the number of zygotes was less than eight and the number of good-quality embryos was less than three) and 1952 patients less than 40 years old in whom embryos were replaced on day 5 (in the case that the number of zygotes was eight or more and/or the number of good-quality embryos was three or more). On the other hand, patients who were 40 years old or more were alloted to day 3 transfer cycles, regardless of the number and quality of the 2-day embryos, due to the possibility of their not producing blastocyst-stage embryos in vitro.
Results: The number of embryos transferred in period II was 2.9 +/- 0.6, while that in period I was 3.7 +/- 0.5. The multiple pregnancy rate was significantly decreased in period II (30.7%) compared to that (49.6%) in period I, while the pregnancy and implantation rates in period II (36.1 and 16.4%, respectively) were not lower than those (34.9 and 16.1%, respectively) in period I. The rate of triplet or more gestations was significantly minimized in period II (2.3%) compared to that in period I (26.5%).
Conclusions: We propose that determination of the date on which embryos should be transferred based on the number and quality of embryos on day 2 may help to maintain an acceptable pregnancy rate, while minimizing embryo transfer failure and high-order multiple gestations.
Similar articles
-
Limiting multiple pregnancy in in vitro fertilization/embryo transfer (IVF-ET) cycles.J Assist Reprod Genet. 1996 Aug;13(7):540-5. doi: 10.1007/BF02066605. J Assist Reprod Genet. 1996. PMID: 8844309
-
Blastocyst transfer: a useful tool for reduction of high-order multiple gestations in a human assisted reproduction program.Am J Obstet Gynecol. 2000 Aug;183(2):377-9; dsicussion 380-2. doi: 10.1067/mob.2000.108090. Am J Obstet Gynecol. 2000. PMID: 10942473
-
Clinical experience employing co-culture of human embryos with autologous human endometrial epithelial cells.Hum Reprod. 2000 Dec;15 Suppl 6:31-8. Hum Reprod. 2000. PMID: 11261481
-
Prevention of multiple pregnancy following IVF in Spain.Reprod Biomed Online. 2006 Dec;13(6):856-63. doi: 10.1016/s1472-6483(10)61035-8. Reprod Biomed Online. 2006. PMID: 17169210 Review.
-
Assisted reproductive technologies: toward improving implantation rates and reducing high-order multiple gestations.Obstet Gynecol Surv. 2002 Aug;57(8):519-29. doi: 10.1097/00006254-200208000-00022. Obstet Gynecol Surv. 2002. PMID: 12187151 Review.
Cited by
-
Clinical outcomes of elective single morula embryo transfer versus elective single blastocyst embryo transfer in IVF-ET.J Assist Reprod Genet. 2012 May;29(5):423-8. doi: 10.1007/s10815-012-9736-8. Epub 2012 Mar 1. J Assist Reprod Genet. 2012. PMID: 22382643 Free PMC article.
-
Comparison of clinical outcomes between single and double vitrified-warmed blastocyst embryo transfer according to the day of vitrification.J Assist Reprod Genet. 2013 Jun;30(6):779-85. doi: 10.1007/s10815-013-0017-y. Epub 2013 May 30. J Assist Reprod Genet. 2013. PMID: 23715875 Free PMC article.
-
Vitrification of human early cavitating and deflated expanded blastocysts: clinical outcome of 474 cycles.J Assist Reprod Genet. 2009 Sep-Oct;26(9-10):523-9. doi: 10.1007/s10815-009-9356-0. Epub 2009 Oct 30. J Assist Reprod Genet. 2009. PMID: 19876729 Free PMC article.
-
Analysis of clinical outcomes with respect to spermatozoan origin after artificial oocyte activation with a calcium ionophore.J Assist Reprod Genet. 2013 Dec;30(12):1569-75. doi: 10.1007/s10815-013-0110-2. Epub 2013 Oct 10. J Assist Reprod Genet. 2013. PMID: 24114629 Free PMC article.
-
Creation, effects on embryo quality, and clinical outcomes of a new embryo culture medium with 31 optimized components derived from human oviduct fluid: A prospective multicenter randomized trial.Reprod Med Biol. 2022 Apr 11;21(1):e12459. doi: 10.1002/rmb2.12459. eCollection 2022 Jan-Dec. Reprod Med Biol. 2022. PMID: 35431648 Free PMC article.
References
-
- Edwards RG, Beard HK. Is the success of human IVF more a matter of genetics and evolution than growing blastocysts? Hum Reprod. 1999;14:1–6. - PubMed
-
- Alves da Motta EL, Alegretti JR, Baracat EC, Olive D, Serafini PC. High implantation and pregnancy rates with transfer of human blastocysts developed in preimplantation stage one and blastocyst media. Fertil Steril. 1998;70:659–663. - PubMed
-
- Gardner DK, Vella P, Lane M, Wagley L, Schlenker T, Schoolcraft WB. Culture and transfer of human blastocysts increases implantation rates and reduces the need for multiple embryo transfers. Fertil Steril. 1998;69:84–88. - PubMed
-
- Jones GM, Trounson AO, Lolatgis N, Wood C. Factors affecting the success of human blastocyst development and pregnancy following in vitro fertilization and embryo transfer. Fertil Steril. 1998;70:1022–1029. - PubMed
-
- Johnston I. The dabate about day five transfer. IVF News. 1997;12:1–2.
MeSH terms
LinkOut - more resources
Full Text Sources